SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

GlaxoSmithKline ups stake in Indian Unit to 72.5%

05 Feb 2013 Evaluate

Pharmaceuticals group GlaxoSmithKline (GSK) has raised its stake in its Indian consumer healthcare subsidiary, i.e. Glaxosmithkline Consumer Healthcare by investing over half a billion pounds in the unit. In an effort to raise its exposure to a key emerging market, GSK, which first announced an open offer back in November, has now raised its stake in the Indian publicly-listed division from 43.2% to 72.5%.

During the offer period, which started January 17 and closed January 30, shareholders of GlaxoSmithKline Consumer Healthcare validly tendered 12.32 million shares, or 29.3% of the total shares outstanding.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Nestle 1374.40
Varun Beverages 541.80
Britannia Inds 5180.00
LT Foods 381.15
Hatsun Agro Product 907.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: